More importantly, experimental findings derived from limiting dilution and tumorigenic assay in vivo further revealed the pivotal roles of TAZ and SOX2 required for HNSCC tumor initiation and overgrowth. The gene discussed is SOX2; the disease is head and neck squamous cell carcinoma.